Bacteriophage for Chronic Multidrug-Resistant Mycobacterium Abscessus Subsp. Abscessus Pulmonary Infection
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: DP-QB-MYA-002.
- Who it may be relevant to
- Registry conditions: Mycobacterium Abscessus Infection, Bacteriophage Therapy, Pulmonary Disease. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Center list to be confirmed — check the primary protocol.
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
DP-QB-MYA-002 Phage Cocktail for Chronic Multidrug-Resistant (MDR) Mycobacterium Abscessus Subsp. Abscessus Pulmonary Infection
Overview
The objective of this study is to evaluate mycobacteriophage therapy using in-vitro validated mycobacteriophage DP-QB-MYA-002 in combination with conventional antimycobacterial agents for the treatment of multidrug-resistant Mycobacterium abscessus pulmonary disease, with the goal of reducing mycobacterial burden and improving pulmonary outcomes.
Interventions
- Biological DP-QB-MYA-002
In-vitro effective Mycobacteriophage DP-QB-MYA-002 against specific strain of Mycobacterium abscessus ssp abscessuss
Primary outcome measures
- Time to Sputum Culture Conversion (Microbiologic Response) [Time frame: 1 year]
Secondary outcome measures (5)
- Change in Volume of Sputum Production (Clinical Response) [Time frame: 1 year]
- Change in frequency of Cough (Clinical Response) [Time frame: 1 year]
- Change in FEV1 (Clinical Response) [Time frame: 1 year]
- Change in BMI (Clinical Response) [Time frame: 1 year]
- Radiographic Response [Time frame: 1 year]
Eligibility criteria
Inclusion criteria
- Consent to participation
Exclusion criteria
- non-consent to participation
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- N/A
- Model
- Single group
- Masking
- Open label
- Primary purpose
- Treatment
Study locations
Center list to be confirmed — check the primary protocol.
Identifiers
NCT: NCT07429162 · PHAGE-2026-01